Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MCTA will rise by +6.73% over the next 2 Weeks and hit $31.33 by Tuesday, February 24, 2026. In that time frame, MCTA's share price is expected to range between $26.14 and $36.49.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 24, 2026 | 27.74 | 33.26 | 38.64 |
| Feb 23, 2026 | 25.82 | 31.29 | 36.78 |
| Feb 20, 2026 | 28.18 | 33.06 | 38.69 |
| Feb 19, 2026 | 29.76 | 35.26 | 40.75 |
| Feb 18, 2026 | 26.23 | 31.92 | 37.21 |
| Feb 17, 2026 | 26.88 | 32.55 | 37.70 |
| Feb 16, 2026 | 25.19 | 30.58 | 35.98 |
| Feb 13, 2026 | 26.68 | 32.35 | 37.89 |
| Feb 12, 2026 | 28.61 | 34.55 | 39.95 |
| Feb 11, 2026 | 25.67 | 31.21 | 36.59 |
MCTA shares rose +6.75% in Tuesday, February 10, 2026's trading session, rising from a previous close of $29.36 to move at $29.36. The stock demonstrated notable intraday movement (see MCTA's key stats for a full breakdown), fluctuating between $29.36 and $29.36, a 0 trading range. While recent weeks have seen some volatility, MCTA has managed to secure a +33.31% gain over the past 2 weeks. The upward price movement was accompanied by remained steady trading volume, with approximately 4.25M shares changing hands, 0 fewer than the previous session. This amounted to $124.80M in total market activity.
Will MCTA Continue Its Upward Trend?
According to analyst ratings and projections for MCTA, Charming Medical Limited Class A Ordinary Shares shares are anticipated to increase by +24.02%, potentially reaching $38.64 per share by February 24, 2026. Short-term technical indicators currently suggest a neutral sentiment for MCTA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 8 positive trading days within the past 30 sessions. Based on the MCTA stock forecast, now is a good time to buy MCTA stock because its current trading price is -11.75% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MCTA covering social and institutional perspectives.
MCTA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MCTA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 78.41% to 80.19%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 78.41%, indicates significant medium-term strength. Insights into MCTA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Charming Medical Class A Ordinary Shares Short-Term Forecasts
MCTA Forecast For Next 5 Days
Our algorithm anticipates Charming Medical Class A Ordinary Shares (MCTA) stock could hit $40.36 by Feb 27, 2026. This represents a +37.50% fall from today's price, following a -5.96% change over the past five days.
MCTA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Charming Medical Limited Class A Ordinary Shares (MCTA) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $30.08, which would mean a +2.47% increase from the current price of $29.36. Projections for this period range from a high of $40.36 to a low of $14.27.
MCTA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Charming Medical Class A Ordinary Shares's price over the next three months point to a rise. MCTA stock is expected to peak at $238.96 on Jul 23, 2026 before potentially dipping to $0.00 on Jul 27, 2026. On average, MCTA is likely to trade around $54.56 in the coming 90 days.
Charming Medical Class A Ordinary Shares Stock Forecast 2025
Based on our predictive models, Charming Medical Class A Ordinary Shares (MCTA) is expected to trade between $0.00 and $564.32 throughout 2026. This would result in an average price of $84.47, potentially offering investors a +187.75% return from current levels.
Charming Medical Limited Class A Ordinary Shares Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Charming Medical Limited Class A Ordinary Shares (MCTA) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $237.32, settling at an average of $96.38. This could translate to a +228.33% gain.
March 2026
Based on current market signals, Charming Medical Limited Class A Ordinary Shares is projected to trend march 2026. We forecast a trading range from $0.00 to $562.62, with a likely average price of $169.14. Investors could expect a potential return of +476.19%.
April 2026
Our predictive algorithms indicate Charming Medical Limited Class A Ordinary Shares stock may see a shift in April 2026. The expected range spans $0.00–$283.24, with an average target of $87.72. This represents a positive outlook and a possible gain of +198.82%.
May 2026
Analyzing established trends, Charming Medical Limited Class A Ordinary Shares looks set to move in May 2026. Projections place the stock between $0.00 and $159.96, averaging around $26.76. This suggests a -8.84% loss from current levels.
June 2026
Market indicators suggest Charming Medical Limited Class A Ordinary Shares could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $210.78, with a midpoint forecast of $66.49. The stock might deliver a +126.50% gain.
July 2026
Forecasting for July 2026, models estimate that Charming Medical Limited Class A Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $238.96, averaging $68.53. This signals a positive trajectory with potential returns around +133.45%.
August 2026
According to our latest forecast models, Charming Medical Limited Class A Ordinary Shares (MCTA) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $564.32, settling at an average of $171.43. This could translate to a +483.99% gain.
September 2026
Based on current market signals, Charming Medical Limited Class A Ordinary Shares is projected to trend september 2026. We forecast a trading range from $0.00 to $289.71, with a likely average price of $84.17. Investors could expect a potential return of +186.73%.
October 2026
Our predictive algorithms indicate Charming Medical Limited Class A Ordinary Shares stock may see a shift in October 2026. The expected range spans $0.00–$184.98, with an average target of $35.87. This represents a positive outlook and a possible gain of +22.19%.
November 2026
Analyzing established trends, Charming Medical Limited Class A Ordinary Shares looks set to move in November 2026. Projections place the stock between $0.00 and $204.28, averaging around $77.95. This suggests a +165.54% gain from current levels.
December 2026
Market indicators suggest Charming Medical Limited Class A Ordinary Shares could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $218.24, with a midpoint forecast of $55.34. The stock might deliver a +88.52% gain.
January 2027
Forecasting for January 2027, models estimate that Charming Medical Limited Class A Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $565.96, averaging $181.82. This signals a positive trajectory with potential returns around +519.38%.
February 2027
According to our latest forecast models, Charming Medical Limited Class A Ordinary Shares (MCTA) is positioned to show a strong performance in February 2027. The price is predicted to move between $27.19 and $207.41, settling at an average of $84.84. This could translate to a +189.01% gain.
MCTA's history of dividends and stock splits also plays a role in long-term investor confidence.

